ID   HCH-3
AC   CVCL_KV96
DR   cancercelllines; CVCL_KV96
DR   Wikidata; Q54881877
RX   DOI=10.4172/2157-2518.1000292;
CC   Population: Japanese.
CC   Doubling time: 82 hours (DOI=10.4172/2157-2518.1000292).
CC   Karyotypic information: Near tetraploid karyotype.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DOI=10.4172/2157-2518.1000292).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Heterozygous (DOI=10.4172/2157-2518.1000292).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
RX   DOI=10.4172/2157-2518.1000292;
RA   Yamada T., Hattori K., Satomi H., Okazaki T., Mori H., Hirose Y.;
RT   "Characterization of a novel cell line (HCH-3) derived from a human
RT   ovarian clear cell carcinoma.";
RL   J. Carcinog. Mutagen. 8:292-292(2017).
//